부산대학교 도서관

Hornung, R; Jurinovic, V; Batcha, AMN; Bamopoulos, SA; Rothenberg-Thurley, M; Amler, S; Sauerlands, MC; Berdel, WE; Wormann, BJ; Bohlander, SK; Braess, J; Hiddemann, W; Lehmann, S; Mareschal, S; Spiekermann, K; Metzeler, KH; Herold, T; Boulesteix, AL

Scientific reports. 8(1):11293

Baumgartner F; Munich Leukemia Laboratory, Munich, Germany.; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, Berlin Institute of Health at Charité (Junior) (Digital) Clinician Scientist Program, Berlin, Germany.; Baer C; Munich Leukemia Laboratory, Munich, Germany.; Bamopoulos S; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, Berlin Institute of Health at Charité (Junior) (Digital) Clinician Scientist Program, Berlin, Germany.; Ayoub E; Munich Leukemia Laboratory, Munich, Germany.; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.; Truger M; Munich Leukemia Laboratory, Munich, Germany.; Meggendorfer M; Munich Leukemia Laboratory, Munich, Germany.; Lenk M; Munich Leukemia Laboratory, Munich, Germany.; Hoermann G; Munich Leukemia Laboratory, Munich, Germany.; Hutter S; Munich Leukemia Laboratory, Munich, Germany.; Müller H; Munich Leukemia Laboratory, Munich, Germany.; Walter W; Munich Leukemia Laboratory, Munich, Germany.; Müller ML; Munich Leukemia Laboratory, Munich, Germany.; Nadarajah N; Munich Leukemia Laboratory, Munich, Germany.; Blombery P; Munich Leukemia Laboratory, Munich, Germany.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Keller U; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center, Berlin, Germany.; Kern W; Munich Leukemia Laboratory, Munich, Germany.; Haferlach C; Munich Leukemia Laboratory, Munich, Germany.; Haferlach T; Munich Leukemia Laboratory, Munich, Germany.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Heynen, G. J.; Baumgartner, F.; Heider, M.; Patra, U.; Holz, M.; Kaiser, M.; Braune, J.; Schaefer, I; Bamopoulos, S. A.; Ramberger, E.; Murgai, A.; Ng, Y. L. D.; Demel, U.; Liebig, S.; Krueger, J.; Janz, M.; Nogai, A.; Schick, M.; Mertins, P.; Mueller, S.; Bassermann, F.; Kroenke, J.; Keller, U.; Wirth, M.

ONCOLOGY RESEARCH AND TREATMENT; SEP 2022, 45 SUPPL 2, p307-p307, 1p. Supplement: 2

Hong Y; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.; TUM School of Medicine, Technical University Munich, 81675 Munich, Germany.; Singh N; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.; TUM School of Medicine, Technical University Munich, 81675 Munich, Germany.; Bamopoulos S; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.; Gjerga E; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.; Schmalbrock LK; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.; Balabanian K; Institut de Recherche Saint Louis, Université de Paris, EMiLy, Inserm U1160, F-75010 Paris, France.; Schick M; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.; Keller U; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.; Max-Delbrück-Center for Molecular Medicine, 13092 Berlin, Germany.; Wirth M; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE

Baumgartner F; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité (Junior) (Digital) Clinician Scientist Program, 10178 Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Bamopoulos SA; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité (Junior) (Digital) Clinician Scientist Program, 10178 Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Faletti L; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, University Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.; Hsiao HJ; Department of Gastroenterology, Infectious Diseases and Rheumatology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Holz M; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Gonzalez-Menendez I; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, Eberhard Karls University of Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' Eberhard Karls University, 72076 Tübingen, Germany.; German Cancer Consortium (DKTK), partner site Tübingen, a partnership between DKFZ and Eberhard Karls University of Tübingen, 72076 Tübingen, Germany.; Solé-Boldo L; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 10115 Berlin, Germany.; Horne A; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 10115 Berlin, Germany.; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Gosavi S; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Özerdem C; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 10115 Berlin, Germany.; Singh N; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Liebig S; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Ramamoorthy S; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, University Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, 79110 Freiburg, Germany.; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, 79110 Freiburg, Germany.; Lehmann M; Department of Gastroenterology, Infectious Diseases and Rheumatology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; iPATH.Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Benjamin Franklin, 12203 Berlin, Germany.; Demel U; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité (Junior) (Digital) Clinician Scientist Program, 10178 Berlin, Germany.; Kühl AA; iPATH.Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Benjamin Franklin, 12203 Berlin, Germany.; Wartewig T; Institute for Clinical Chemistry and Pathobiochemistry, Technische Universität München, 81675 Munich, Germany.; Center of Molecular and Cellular Oncology, Yale School of Medicine, Yale University, New Haven, CT 06510, USA.; Ruland J; Institute for Clinical Chemistry and Pathobiochemistry, Technische Universität München, 81675 Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and Technische Universität München, 81675 Munich, Germany.; Wunderlich FT; Obesity and Cancer, Max Planck Institute for Metabolism Research, 50931 Cologne, Germany.; Schick M; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Walther W; Experimental and Clinical Research Center, Charité Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Robert-Rössle Str. 10, 13125 Berlin, Germany.; EPO GmbH Berlin-Buch, Robert-Rössle-Str. 10, 13125 Berlin, Germany.; Rose-John S; Institute of Biochemistry, Christian-Albrechts-Universität zu Kiel, 24118 Kiel, Germany.; Haas S; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 10115 Berlin, Germany.; Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ - ZMBH Alliance, 69120 Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany.; Quintanilla-Martinez L; Institute of Pathology and Neuropathology, Comprehensive Cancer Center, Eberhard Karls University of Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' Eberhard Karls University, 72076 Tübingen, Germany.; German Cancer Consortium (DKTK), partner site Tübingen, a partnership between DKFZ and Eberhard Karls University of Tübingen, 72076 Tübingen, Germany.; Feske S; Department of Pathology, New York University School of Medicine, New York, NY 10016, USA.; Ehl S; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, University Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.; Glauben R; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Department of Gastroenterology, Infectious Diseases and Rheumatology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Keller U; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101465400 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1937-9145 (Electronic) Linking ISSN: 19450877 NLM ISO Abbreviation: Sci Signal Subsets: MEDLINE

Heynen GJJE; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Baumgartner F; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité (Junior) (Digital) Clinician Scientist Program, Berlin, Germany.; Heider M; Internal Medicine III, School of Medicine, Technische Universität München, Munich, Germany.; Patra U; Institute of Biochemistry II, Goethe University, Medical School, Frankfurt, Germany.; Holz M; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Braune J; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Kaiser M; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Schäffer I; Internal Medicine III, School of Medicine, Technische Universität München, Munich, Germany.; Bamopoulos SA; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité (Junior) (Digital) Clinician Scientist Program, Berlin, Germany.; Ramberger E; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health, Berlin, Germany.; Murgai A; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Ng YLD; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Demel UM; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité (Junior) (Digital) Clinician Scientist Program, Berlin, Germany.; Laue D; Department of Traumatology and Reconstructive Surgery, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Liebig S; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Krüger J; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Janz M; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health, Berlin, Germany.; Nogai A; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Schick M; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Mertins P; Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health, Berlin, Germany.; Müller S; Institute of Biochemistry II, Goethe University, Medical School, Frankfurt, Germany.; Bassermann F; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Internal Medicine III, School of Medicine, Technische Universität München, Munich, Germany.; Krönke J; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Keller U; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health, Berlin, Germany.; Wirth M; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Batcha AMN; Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.; Data Integration for Future Medicine (DIFUTURE), LMU Munich, Munich, Germany.; Buckup N; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; Bamopoulos SA; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité University Medicine Berlin, Berlin, Germany.; Jurinovic V; Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; Rothenberg-Thurley M; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; Gittinger H; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; Ksienzyk B; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; Dufour A; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; Schneider S; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; Institute of Human Genetics, University Hospital, LMU Munich, Munich, Germany.; Kontro M; Department of Haematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.; Foundation for the Finnish Cancer Institute, Helsinki, Finland.; Saad J; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.; Heckmann CA; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.; Sauerland C; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.; Görlich D; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.; Berdel WE; Department of Medicine A, Hematology and Oncology, University of Münster, Münster, Germany.; Wörmann BJ; German Society of Hematology and Oncology, Berlin, Germany.; Krug U; Department of Medicine III, Hospital Leverkusen, Leverkusen, Germany.; Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany.; Mansmann U; Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.; Data Integration for Future Medicine (DIFUTURE), LMU Munich, Munich, Germany.; German Cancer Consortium, Heidelberg, Germany.; German Cancer Research Center, Heidelberg, Germany.; Hiddemann W; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium, Heidelberg, Germany.; German Cancer Research Center, Heidelberg, Germany.; Spiekermann K; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium, Heidelberg, Germany.; German Cancer Research Center, Heidelberg, Germany.; Metzeler KH; Department of Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.; Herold T; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium, Heidelberg, Germany.; German Cancer Research Center, Heidelberg, Germany.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Doffo J; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; Bamopoulos SA; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; Köse H; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; Orben F; Department of Medicine II (Gastroenterology and GI Oncology), Klinikum Rechts der Isar, School of Medicine, Technische Universität München, 81675 München, Germany.; Zang C; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; Pons M; Department of Toxicology, University Medical Center, 55131 Mainz, Germany.; den Dekker AT; Center for Biomics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Cell Biology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Brouwer RWW; Center for Biomics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Cell Biology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Baluapuri A; Cancer Systems Biology Group, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, 97070 Würzburg, Germany.; Habringer S; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; Reichert M; Department of Medicine II (Gastroenterology and GI Oncology), Klinikum Rechts der Isar, School of Medicine, Technische Universität München, 81675 München, Germany.; Illendula A; Department of Pharmacology, University of Virginia, Charlottesville, VA 22903.; Krämer OH; Department of Toxicology, University Medical Center, 55131 Mainz, Germany.; Schick M; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; Wolf E; Cancer Systems Biology Group, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, 97070 Würzburg, Germany.; van IJcken WFJ; Center for Biomics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Cell Biology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Esposito I; Institute of Pathology, Heinrich Heine University and University Hospital of Düsseldorf, 40225 Düsseldorf, Germany.; Keller U; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.; German Cancer Research Center, 69120 Heidelberg, Germany.; German Cancer Consortium, 69120 Heidelberg, Germany.; Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany.; Schneider G; Department of Toxicology, University Medical Center, 55131 Mainz, Germany.; German Cancer Research Center, 69120 Heidelberg, Germany.; Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany.; Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, 37075 Göttingen, Germany.; Wirth M; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany; matthias.wirth@charite.de.

Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

Bamopoulos SA; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. stefanos.bamopoulos@charite.de.; Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité University Medicine Berlin, Berlin, Germany. stefanos.bamopoulos@charite.de.; Batcha AMN; Institute for Medical Information Processing Biometry and Epidemiology, LMU Munich, Munich, Germany.; DIFUTURE (Data Integration for Future Medicine (DiFuture, www.difuture.de), LMU Munich, Munich, Germany.; Jurinovic V; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Institute for Medical Information Processing Biometry and Epidemiology, LMU Munich, Munich, Germany.; Rothenberg-Thurley M; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Janke H; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Ksienzyk B; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Philippou-Massier J; Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Munich, Germany.; Graf A; Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Munich, Germany.; Krebs S; Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Munich, Germany.; Blum H; Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Munich, Germany.; Schneider S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Institute of Human Genetics, University Hospital, LMU Munich, Munich, Germany.; Konstandin N; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Sauerland MC; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.; Görlich D; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.; Berdel WE; Department of Medicine, Hematology and Oncology, University of Münster, Münster, Germany.; Woermann BJ; German Society of Hematology and Oncology, Berlin, Germany.; Bohlander SK; Leukemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.; Canzar S; Gene Center, LMU Munich, Munich, Germany.; Mansmann U; Institute for Medical Information Processing Biometry and Epidemiology, LMU Munich, Munich, Germany.; DIFUTURE (Data Integration for Future Medicine (DiFuture, www.difuture.de), LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany.; Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Metzeler KH; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Herold T; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. tobias.herold@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. tobias.herold@med.uni-muenchen.de.; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Center for Environmental Health (HMGU), Munich, Germany. tobias.herold@med.uni-muenchen.de.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Opatz S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bamopoulos SA; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Metzeler KH; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Herold T; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Ksienzyk B; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Bräundl K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Tschuri S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Vosberg S; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Konstandin NP; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Wang C; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Hartmann L; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Graf A; Laboratory for Functional Genome Analysis at the Gene Center, LMU Munich, Munich, Germany.; Krebs S; Laboratory for Functional Genome Analysis at the Gene Center, LMU Munich, Munich, Germany.; Blum H; Laboratory for Functional Genome Analysis at the Gene Center, LMU Munich, Munich, Germany.; Schneider S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Institute of Human Genetics, University Hospital, LMU Munich, Munich, Germany.; Thiede C; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany.; Middeke JM; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany.; Stölzel F; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany.; Röllig C; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany.; Schetelig J; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany.; Ehninger G; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany.; Krämer A; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Braess J; Oncology and Hematology, St. John of God Hospital, Regensburg, Germany.; Görlich D; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.; Sauerland MC; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.; Berdel WE; Department of Medicine A, Hematology, Oncology and Pneumology, University of Münster, Münster, Germany.; Wörmann BJ; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow, Berlin, Germany.; Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bohlander SK; Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.; Greif PA; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. pgreif@med.uni-muenchen.de.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. pgreif@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. pgreif@med.uni-muenchen.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. pgreif@med.uni-muenchen.de.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE